|
Volumn 276, Issue 7399, 2006, Pages 543-
|
Problems in the pharmacovigilance of herbal medicines in the UK highlighted
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AFLATOXIN B1;
AFLATOXIN B2;
AFLATOXIN G1;
AFLATOXIN G2;
ALCOHOL;
ANTICOAGULANT AGENT;
CHLORPROPAMIDE;
DIGOXIN;
FUMONISIN;
GARLIC EXTRACT;
GINKGO BILOBA EXTRACT;
GINSENG EXTRACT;
HERBACEOUS AGENT;
HYPERICUM PERFORATUM EXTRACT;
MYCOTOXIN;
OCHRATOXIN;
OPIATE;
ORAL CONTRACEPTIVE AGENT;
PATULIN;
SALVIA MILTIORRHIZA EXTRACT;
TRAZODONE;
TRICHOTHECENE;
WARFARIN;
ZEARALENONE;
ACCESS TO INFORMATION;
CONFERENCE PAPER;
DRUG ALCOHOL INTERACTION;
DRUG CONTAMINATION;
DRUG INFORMATION;
DRUG LABELING;
DRUG NOMENCLATURE;
DRUG QUALITY;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
GOOD MANUFACTURING PRACTICE;
HUMAN;
INFORMATION PROCESSING;
INTERPERSONAL COMMUNICATION;
LICENCE;
MEDICAL EDUCATION;
MEDICAL LITERATURE;
PATIENT MONITORING;
PHARMACIST ATTITUDE;
POSTGRADUATE EDUCATION;
PRESCRIPTION;
PROFESSIONAL COMPETENCE;
PUBLIC HEALTH SERVICE;
RESPONSIBILITY;
RISK ASSESSMENT;
RISK MANAGEMENT;
SAFETY;
UNITED KINGDOM;
UNSPECIFIED SIDE EFFECT;
|
EID: 33646565666
PISSN: 00316873
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (8)
|
References (0)
|